.Pharmacolibrary.Drugs.C_CardiovascularSystem.C09D_AngiotensinIiReceptorBlockersArbsCombinations.C09DX05_ValsartanAndNebivolol.ValsartanAndNebivolol .Pharmacolibrary.Drugs.C_CardiovascularSystem.C09D_AngiotensinIiReceptorBlockersArbsCombinations.C09DX05_ValsartanAndNebivolol.ValsartanAndNebivolol| name: | ValsartanAndNebivolol |
| ATC code: | C09DX05 | route: | oral |
| n-compartments | 1 |
Valsartan and nebivolol is a fixed-dose antihypertensive combination containing an angiotensin II receptor blocker (valsartan) and a beta-1 selective adrenergic blocker (nebivolol). This combination is used for the treatment of essential hypertension in adults and may provide synergistic blood pressure-lowering effects. It is approved for use in several countries.
No published study reports pharmacokinetic model parameters specifically for the valsartan/nebivolol fixed combination. Estimates are provided below based on known PK data for monotherapy in healthy adults.